| Michelle Thompson, | |
|
705 Brookshire Dr Ste 2, Suite 2, Hermitage, PA 16148-4513 | |
| (724) 347-4099 | |
| Not Available |
| Full Name | Michelle Thompson |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 21 Years |
| Location | 705 Brookshire Dr Ste 2, Hermitage, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326083387 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OS013132 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Upmc Horizon | Greenville, PA | Hospital |
| Upmc Jameson | New castle, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Upmc Community Medicine Inc | 2062318975 | 690 |
| University Of Pittsburgh Physicians | 8729990239 | 3721 |
News Archive
Giving birth at home is the most significant risk factor for neonatal deaths in major sections of Africa - a continent that continues to be plagued by the highest neonatal mortality rates in the world, indicates a new study by Michigan State University scholars.
Although incident parasomnias are uncommon as children enter adolescence, parasomnias present in preadolescents may persist into the teen years, according to a research abstract that will be presented Monday, June 7, 2010, in San Antonio, Texas, at SLEEP 2010, the 24th annual meeting of the Associated Professional Sleep Societies LLC.
If you're one of Australia's 1.4 million shift workers, you'll know that managing irregular hours can be hard, disrupting normal eating and sleeping patterns, and reducing the opportunity for regular exercise.
Regeneron Pharmaceuticals, Inc. and Sanofi announced today that a Phase 3 study of sarilumab, an investigational, fully human IL-6 receptor antibody, met its co-primary efficacy endpoints of a greater improvement in signs and symptoms of rheumatoid arthritis (RA) at 24 weeks and physical function at 12 weeks, compared to placebo.
› Verified 9 days ago
| Entity Name | Upmc Community Medicine Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558976092 PECOS PAC ID: 2062318975 Enrollment ID: O20040217000388 |
News Archive
Giving birth at home is the most significant risk factor for neonatal deaths in major sections of Africa - a continent that continues to be plagued by the highest neonatal mortality rates in the world, indicates a new study by Michigan State University scholars.
Although incident parasomnias are uncommon as children enter adolescence, parasomnias present in preadolescents may persist into the teen years, according to a research abstract that will be presented Monday, June 7, 2010, in San Antonio, Texas, at SLEEP 2010, the 24th annual meeting of the Associated Professional Sleep Societies LLC.
If you're one of Australia's 1.4 million shift workers, you'll know that managing irregular hours can be hard, disrupting normal eating and sleeping patterns, and reducing the opportunity for regular exercise.
Regeneron Pharmaceuticals, Inc. and Sanofi announced today that a Phase 3 study of sarilumab, an investigational, fully human IL-6 receptor antibody, met its co-primary efficacy endpoints of a greater improvement in signs and symptoms of rheumatoid arthritis (RA) at 24 weeks and physical function at 12 weeks, compared to placebo.
› Verified 9 days ago
| Entity Name | University Of Pittsburgh Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619935004 PECOS PAC ID: 8729990239 Enrollment ID: O20040308000883 |
News Archive
Giving birth at home is the most significant risk factor for neonatal deaths in major sections of Africa - a continent that continues to be plagued by the highest neonatal mortality rates in the world, indicates a new study by Michigan State University scholars.
Although incident parasomnias are uncommon as children enter adolescence, parasomnias present in preadolescents may persist into the teen years, according to a research abstract that will be presented Monday, June 7, 2010, in San Antonio, Texas, at SLEEP 2010, the 24th annual meeting of the Associated Professional Sleep Societies LLC.
If you're one of Australia's 1.4 million shift workers, you'll know that managing irregular hours can be hard, disrupting normal eating and sleeping patterns, and reducing the opportunity for regular exercise.
Regeneron Pharmaceuticals, Inc. and Sanofi announced today that a Phase 3 study of sarilumab, an investigational, fully human IL-6 receptor antibody, met its co-primary efficacy endpoints of a greater improvement in signs and symptoms of rheumatoid arthritis (RA) at 24 weeks and physical function at 12 weeks, compared to placebo.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michelle Thompson, 705 Brookshire Dr Ste 2, Suite 2, Hermitage, PA 16148-4513 Ph: () - | Michelle Thompson, 705 Brookshire Dr Ste 2, Suite 2, Hermitage, PA 16148-4513 Ph: (724) 347-4099 |
News Archive
Giving birth at home is the most significant risk factor for neonatal deaths in major sections of Africa - a continent that continues to be plagued by the highest neonatal mortality rates in the world, indicates a new study by Michigan State University scholars.
Although incident parasomnias are uncommon as children enter adolescence, parasomnias present in preadolescents may persist into the teen years, according to a research abstract that will be presented Monday, June 7, 2010, in San Antonio, Texas, at SLEEP 2010, the 24th annual meeting of the Associated Professional Sleep Societies LLC.
If you're one of Australia's 1.4 million shift workers, you'll know that managing irregular hours can be hard, disrupting normal eating and sleeping patterns, and reducing the opportunity for regular exercise.
Regeneron Pharmaceuticals, Inc. and Sanofi announced today that a Phase 3 study of sarilumab, an investigational, fully human IL-6 receptor antibody, met its co-primary efficacy endpoints of a greater improvement in signs and symptoms of rheumatoid arthritis (RA) at 24 weeks and physical function at 12 weeks, compared to placebo.
› Verified 9 days ago
Thomas Armour, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 102 N Keel Ridge Rd, Hermitage, PA 16148 Phone: 800-471-8592 | |
Dr. Heather Joy Porter, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 480 N Kerrwood Dr, Suite 102, Hermitage, PA 16148 Phone: 724-981-0823 Fax: 724-981-6409 | |
Iftikhar Ahmed Chatha, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2500 Highland Rd Ste 102, Hermitage, PA 16148 Phone: 724-981-7003 Fax: 724-981-2171 | |
Dr. Daniel A Bee, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3110 Highland Rd, Suite 203, Hermitage, PA 16148 Phone: 724-981-0825 Fax: 724-981-4074 | |
Dr. Mary Lynn D'auria, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 480 N Kerrwood Dr, Suite 102, Hermitage, PA 16148 Phone: 724-981-0823 Fax: 724-981-6409 | |
Dr. Adam Keith Lucich, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 449 N Hermitage Rd, Hermitage, PA 16148 Phone: 724-962-3528 |